Group 1 - The article discusses the recent changes in the U.S. tariff policy regarding pharmaceuticals, stating that the new tariffs will not apply to countries that have trade agreements with the U.S. [3][4] - On September 26, U.S. pharmaceutical stocks showed mixed performance, with Novavax rising by 2.52% and Pfizer increasing by 0.68%, while Moderna and UnitedHealth saw declines of 0.49% and 0.43%, respectively [3]. - The U.S. will impose a 100% tariff on imported brand-name or patented drugs starting October 1, unless companies establish manufacturing facilities in the U.S. [6]. Group 2 - The White House confirmed that the new tariffs on pharmaceuticals will adhere to existing agreements, maintaining a 15% tariff cap for the EU and Japan [4]. - British officials indicated that the UK is willing to negotiate higher prices for certain pharmaceuticals to protect exports to the U.S. [5]. - The Canadian steel industry has faced significant declines in production and exports due to U.S. tariffs, with a 24.8% drop in output since March and a 25.5% decrease in exports of non-alloy steel by July [7][8].
关税突变！白宫最新发声！
天天基金网·2025-09-27 02:44